Inveltys
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.inveltys.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Inveltys
Alcon Inc. specializes in ophthalmic products, including the INVELTYS® (loteprednol etabonate ophthalmic suspension) 1% drops, which are designed for the treatment of post-operative inflammation and pain following ocular surgery. Their offerings include a variety of surgical equipment, contact lenses, and prescription drugs aimed at professionals in the cataract, refractive, and vitreoretinal fields. The company targets healthcare professionals, particularly ophthalmologists, with a focus on providing advanced technology and patient support resources. Alcon also emphasizes safety information and patient eligibility for savings programs associated with their products.Explore more
Popular SearchesInveltysSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inveltys your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Inveltys recently announced quarterly report
Funding: Get notified immidiatlly once Inveltys has new funding data
Check if Inveltys has recently received funding, and reach out quickly before it becomes old news!
Inveltys, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Inveltys launches new products
Click to see if Inveltys had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Inveltys
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Inveltys is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Inveltys
Find 3 more new buyers
Compare Similar Companies to Inveltys
Compare insights from companies similar to Inveltys, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Inveltys
<$5M
11-50
Private
-
2019
N/A
Inveltys Tech Stack
A closer look at the technologies used by Inveltys
Inveltys News & Media
Kala Announces Entry into Definitive Agreement to Sell EYSUVIS® and INVELTYS® to Alcon Inc.
--Kala Will Receive $60 Million in Upfront Payment; Eligible to Receive Additional Sales-Based Milestone Payments-- --Kala Will Focus Resources on Phase 2/3 Trial of KPI-012 for Orphan Disease Persistent Corneal Epithelial Defect-- ARLINGTON, Mass., May 23, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Inveltys
Sign Up For FreeTo access detailed company insights
Alcon Inc. specializes in ophthalmic products, including the INVELTYS® (loteprednol etabonate ophthalmic suspension) 1% drops, which are designed for the treatment of post-operative inflammation and pain following ocular surgery. Their offerings include a variety of surgical equipment, contact lenses, and prescription drugs aimed at professionals i... Read More
